发明名称 Compositions for oral administration of zoledronic acid or related compounds for treating disease
摘要 Oral dosage forms of bisphosphonate compounds, such as zoledronic acid, can be used to treat or alleviate pain or related conditions. The oral bioavailability of zoledronic acid can be enhanced by administering the zoledronic acid in the disodium salt form.
申请公布号 US8802658(B2) 申请公布日期 2014.08.12
申请号 US201314063979 申请日期 2013.10.25
申请人 Antecip Bioventures II LLC 发明人 Tabuteau Herriot
分类号 A61K31/66;A61K9/00;A61K31/675 主分类号 A61K31/66
代理机构 K&L Gates LLP 代理人 K&L Gates LLP ;Cullman Louis C.;Johnson Brent A.
主权项 1. A method of enhancing the oral bioavailability of zoledronic acid comprising orally administering a dosage form containing zoledronic acid in the disodium salt form to a mammal in need of treatment by zoledronic acid.
地址 New York NY US
您可能感兴趣的专利